ヒト血漿由来治療薬の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Human Plasma-Derived Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012B0508 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、ヒト血漿由来治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト血漿由来治療薬の種類別市場規模（アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体濃縮物、その他）、用途別市場規模（病院、クリニック、研究センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Alkahest、Octapharma、Entegrion, Inc.、Baxter、Kedrion、CSL Behring、Sanquin、Grifols、Gammagard、Prometic Life Sciences、Takeda、 ・地域別グローバル市場分析 2015年-2020年 ・ヒト血漿由来治療薬の北米市場（アメリカ、カナダ、メキシコ） ・ヒト血漿由来治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒト血漿由来治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒト血漿由来治療薬の南米市場（ブラジル、アルゼンチン） ・ヒト血漿由来治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体濃縮物、その他 ・用途別分析：病院、クリニック、研究センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Human Plasma-Derived Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Human Plasma-Derived Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Human Plasma-Derived Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Human Plasma-Derived Therapeutics market has been segmented into:
Albumin
Immunoglobulin
Clotting Factor
Prothrombin Complex
Others

By Application, Human Plasma-Derived Therapeutics has been segmented into:
Hospital
Clinic
Research Center

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Plasma-Derived Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Plasma-Derived Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Plasma-Derived Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Human Plasma-Derived Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Human Plasma-Derived Therapeutics Market Share Analysis
Human Plasma-Derived Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Plasma-Derived Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Plasma-Derived Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Human Plasma-Derived Therapeutics are:
Alkahest
Octapharma
Entegrion, Inc.
Baxter
Kedrion
CSL Behring
Sanquin
Grifols
Gammagard
Prometic Life Sciences
Takeda

レポート目次

---

Table of Contents

1 Human Plasma-Derived Therapeutics Market Overview
1.1 Product Overview and Scope of Human Plasma-Derived Therapeutics
1.2 Classification of Human Plasma-Derived Therapeutics by Type
1.2.1 Global Human Plasma-Derived Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Human Plasma-Derived Therapeutics Revenue Market Share by Type in 2019
1.2.3 Albumin
1.2.4 Immunoglobulin
1.2.5 Clotting Factor
1.2.6 Prothrombin Complex
1.2.7 Others
1.3 Global Human Plasma-Derived Therapeutics Market by Application
1.3.1 Overview: Global Human Plasma-Derived Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Global Human Plasma-Derived Therapeutics Market by Regions
1.4.1 Global Human Plasma-Derived Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Human Plasma-Derived Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Human Plasma-Derived Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Human Plasma-Derived Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Plasma-Derived Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Human Plasma-Derived Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Plasma-Derived Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Alkahest
2.1.1 Alkahest Details
2.1.2 Alkahest Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alkahest SWOT Analysis
2.1.4 Alkahest Product and Services
2.1.5 Alkahest Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Octapharma SWOT Analysis
2.2.4 Octapharma Product and Services
2.2.5 Octapharma Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Entegrion, Inc.
2.3.1 Entegrion, Inc. Details
2.3.2 Entegrion, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Entegrion, Inc. SWOT Analysis
2.3.4 Entegrion, Inc. Product and Services
2.3.5 Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Baxter SWOT Analysis
2.4.4 Baxter Product and Services
2.4.5 Baxter Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kedrion SWOT Analysis
2.5.4 Kedrion Product and Services
2.5.5 Kedrion Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 CSL Behring
2.6.1 CSL Behring Details
2.6.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 CSL Behring SWOT Analysis
2.6.4 CSL Behring Product and Services
2.6.5 CSL Behring Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanquin
2.7.1 Sanquin Details
2.7.2 Sanquin Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanquin SWOT Analysis
2.7.4 Sanquin Product and Services
2.7.5 Sanquin Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Grifols
2.8.1 Grifols Details
2.8.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Grifols SWOT Analysis
2.8.4 Grifols Product and Services
2.8.5 Grifols Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Gammagard
2.9.1 Gammagard Details
2.9.2 Gammagard Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Gammagard SWOT Analysis
2.9.4 Gammagard Product and Services
2.9.5 Gammagard Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Prometic Life Sciences
2.10.1 Prometic Life Sciences Details
2.10.2 Prometic Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Prometic Life Sciences SWOT Analysis
2.10.4 Prometic Life Sciences Product and Services
2.10.5 Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takeda
2.11.1 Takeda Details
2.11.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Takeda SWOT Analysis
2.11.4 Takeda Product and Services
2.11.5 Takeda Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Human Plasma-Derived Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Plasma-Derived Therapeutics Players Market Share
3.2.2 Top 10 Human Plasma-Derived Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Human Plasma-Derived Therapeutics Revenue and Market Share by Regions
4.2 North America Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Human Plasma-Derived Therapeutics Revenue by Countries
5.1 North America Human Plasma-Derived Therapeutics Revenue by Countries (2015-2020)
5.2 USA Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Human Plasma-Derived Therapeutics Revenue by Countries
6.1 Europe Human Plasma-Derived Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Human Plasma-Derived Therapeutics Revenue by Countries
7.1 Asia-Pacific Human Plasma-Derived Therapeutics Revenue by Countries (2015-2020)
7.2 China Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Human Plasma-Derived Therapeutics Revenue by Countries
8.1 South America Human Plasma-Derived Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Human Plasma-Derived Therapeutics by Countries
9.1 Middle East & Africa Human Plasma-Derived Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Human Plasma-Derived Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Human Plasma-Derived Therapeutics Market Forecast by Type (2019-2024)
10.3 Albumin Revenue Growth Rate (2015-2025)
10.4 Immunoglobulin Revenue Growth Rate (2015-2025)
10.5 Clotting Factor Revenue Growth Rate (2015-2025)
10.6 Prothrombin Complex Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Human Plasma-Derived Therapeutics Market Segment by Application
11.1 Global Human Plasma-Derived Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Human Plasma-Derived Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Research Center Revenue Growth (2015-2020)
12 Global Human Plasma-Derived Therapeutics Market Size Forecast (2021-2025)
12.1 Global Human Plasma-Derived Therapeutics Market Size Forecast (2021-2025)
12.2 Global Human Plasma-Derived Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Human Plasma-Derived Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Plasma-Derived Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Plasma-Derived Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Human Plasma-Derived Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Alkahest Corporate Information, Location and Competitors
Table 6. Alkahest Human Plasma-Derived Therapeutics Major Business
Table 7. Alkahest Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Alkahest SWOT Analysis
Table 9. Alkahest Human Plasma-Derived Therapeutics Product and Solutions
Table 10. Alkahest Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Octapharma Corporate Information, Location and Competitors
Table 12. Octapharma Human Plasma-Derived Therapeutics Major Business
Table 13. Octapharma Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Octapharma SWOT Analysis
Table 15. Octapharma Human Plasma-Derived Therapeutics Product and Solutions
Table 16. Octapharma Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Entegrion, Inc. Corporate Information, Location and Competitors
Table 18. Entegrion, Inc. Human Plasma-Derived Therapeutics Major Business
Table 19. Entegrion, Inc. Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Entegrion, Inc. SWOT Analysis
Table 21. Entegrion, Inc. Human Plasma-Derived Therapeutics Product and Solutions
Table 22. Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Baxter Corporate Information, Location and Competitors
Table 24. Baxter Human Plasma-Derived Therapeutics Major Business
Table 25. Baxter Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Baxter SWOT Analysis
Table 27. Baxter Human Plasma-Derived Therapeutics Product and Solutions
Table 28. Baxter Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Kedrion Corporate Information, Location and Competitors
Table 30. Kedrion Human Plasma-Derived Therapeutics Major Business
Table 31. Kedrion Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Kedrion SWOT Analysis
Table 33. Kedrion Human Plasma-Derived Therapeutics Product and Solutions
Table 34. Kedrion Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. CSL Behring Corporate Information, Location and Competitors
Table 36. CSL Behring Human Plasma-Derived Therapeutics Major Business
Table 37. CSL Behring Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. CSL Behring SWOT Analysis
Table 39. CSL Behring Human Plasma-Derived Therapeutics Product and Solutions
Table 40. CSL Behring Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sanquin Corporate Information, Location and Competitors
Table 42. Sanquin Human Plasma-Derived Therapeutics Major Business
Table 43. Sanquin Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Sanquin SWOT Analysis
Table 45. Sanquin Human Plasma-Derived Therapeutics Product and Solutions
Table 46. Sanquin Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Grifols Corporate Information, Location and Competitors
Table 48. Grifols Human Plasma-Derived Therapeutics Major Business
Table 49. Grifols Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Grifols SWOT Analysis
Table 51. Grifols Human Plasma-Derived Therapeutics Product and Solutions
Table 52. Grifols Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Gammagard Corporate Information, Location and Competitors
Table 54. Gammagard Human Plasma-Derived Therapeutics Major Business
Table 55. Gammagard Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Gammagard SWOT Analysis
Table 57. Gammagard Human Plasma-Derived Therapeutics Product and Solutions
Table 58. Gammagard Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Prometic Life Sciences Corporate Information, Location and Competitors
Table 60. Prometic Life Sciences Human Plasma-Derived Therapeutics Major Business
Table 61. Prometic Life Sciences Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Prometic Life Sciences SWOT Analysis
Table 63. Prometic Life Sciences Human Plasma-Derived Therapeutics Product and Solutions
Table 64. Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Takeda Corporate Information, Location and Competitors
Table 66. Takeda Human Plasma-Derived Therapeutics Major Business
Table 67. Takeda Human Plasma-Derived Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Takeda SWOT Analysis
Table 69. Takeda Human Plasma-Derived Therapeutics Product and Solutions
Table 70. Takeda Human Plasma-Derived Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Human Plasma-Derived Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 72. Global Human Plasma-Derived Therapeutics Revenue Share by Players (2015-2020)
Table 73. Global Human Plasma-Derived Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Human Plasma-Derived Therapeutics Revenue Market Share by Regions (2015-2020)
Table 75. North America Human Plasma-Derived Therapeutics Revenue by Countries (2015-2020)
Table 76. North America Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Table 77. Europe Human Plasma-Derived Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Human Plasma-Derived Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Human Plasma-Derived Therapeutics Revenue by Countries (2015-2020)
Table 80. South America Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Human Plasma-Derived Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Table 83. Global Human Plasma-Derived Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 84. Global Human Plasma-Derived Therapeutics Revenue Share by Type (2015-2020)
Table 85. Global Human Plasma-Derived Therapeutics Revenue Forecast by Type (2021-2025)
Table 86. Global Human Plasma-Derived Therapeutics Revenue by Application (2015-2020)
Table 87. Global Human Plasma-Derived Therapeutics Revenue Share by Application (2015-2020)
Table 88. Global Human Plasma-Derived Therapeutics Revenue Forecast by Application (2021-2025)
Table 89. Global Human Plasma-Derived Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Human Plasma-Derived Therapeutics Picture
Figure 2. Global Human Plasma-Derived Therapeutics Revenue Market Share by Type in 2019
Figure 3. Albumin Picture
Figure 4. Immunoglobulin Picture
Figure 5. Clotting Factor Picture
Figure 6. Prothrombin Complex Picture
Figure 7. Others Picture
Figure 8. Human Plasma-Derived Therapeutics Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Research Center Picture
Figure 12. Global Human Plasma-Derived Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Human Plasma-Derived Therapeutics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Human Plasma-Derived Therapeutics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Human Plasma-Derived Therapeutics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Human Plasma-Derived Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Human Plasma-Derived Therapeutics Revenue Market Share by Regions in 2018
Figure 26. North America Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. South America Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. North America Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Human Plasma-Derived Therapeutics Revenue Market Share by Countries in 2019
Figure 33. USA Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Human Plasma-Derived Therapeutics Revenue Market Share by Countries in 2019
Figure 38. Germany Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. UK Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. France Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Human Plasma-Derived Therapeutics Revenue Market Share by Countries in 2019
Figure 45. China Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. India Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. South America Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Human Plasma-Derived Therapeutics Revenue Market Share by Countries in 2019
Figure 52. Brazil Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Human Plasma-Derived Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Human Plasma-Derived Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Human Plasma-Derived Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Global Human Plasma-Derived Therapeutics Revenue Share by Type (2015-2020)
Figure 61. Global Human Plasma-Derived Therapeutics Revenue Share by Type in 2019
Figure 62. Global Human Plasma-Derived Therapeutics Market Share Forecast by Type (2021-2025)
Figure 63. Global Albumin Revenue Growth Rate (2015-2020)
Figure 64. Global Immunoglobulin Revenue Growth Rate (2015-2020)
Figure 65. Global Clotting Factor Revenue Growth Rate (2015-2020)
Figure 66. Global Prothrombin Complex Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Human Plasma-Derived Therapeutics Revenue Share by Application (2015-2020)
Figure 69. Global Human Plasma-Derived Therapeutics Revenue Share by Application in 2019
Figure 70. Global Human Plasma-Derived Therapeutics Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Clinic Revenue Growth Rate (2015-2020)
Figure 73. Global Research Center Revenue Growth Rate (2015-2020)
Figure 74. Global Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Human Plasma-Derived Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Human Plasma-Derived Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Europe Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. South America Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Human Plasma-Derived Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---